# Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis

> **NCT06499415** · PHASE4 · RECRUITING · sponsor: **Maastricht University Medical Center** · enrollment: 232 (estimated)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DRUG:** 5FU-Calcipotriol
- **DRUG:** 5-FU 50 MG/ML Topical Cream

## Key facts

- **NCT ID:** NCT06499415
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-04
- **Primary completion:** 2029-03-02
- **Final completion:** 2029-03-02
- **Target enrollment:** 232 (ESTIMATED)
- **Last updated:** 2025-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06499415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06499415, "Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06499415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*